Emergent BioSolutions Inc. (FRA:ER4)

Emergent BioSolutions Revenue

Emergent BioSolutions had revenue of $231.10M USD in the quarter ending September 30, 2025, a decrease of -21.34%. This brings the company's revenue in the last twelve months to $788.90M, down -29.91% year-over-year. In the year 2024, Emergent BioSolutions had annual revenue of $1.04B, down -0.54%.

• Revenue (ttm): $788.90M
• Revenue Growth: -29.91%
• P/S Ratio: 0.72
• Revenue / Employee: $876.56K
• Employees: 900
• Market Cap: 487.47M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04B	-5.70M	-0.54%
Dec 31, 2023	1.05B	-68.20M	-6.10%
Dec 31, 2022	1.12B	-656.10M	-36.99%
Dec 31, 2021	1.77B	196.30M	12.45%
Dec 31, 2020	1.58B	471.30M	42.61%
Dec 31, 2019	1.11B	323.60M	41.36%
Dec 31, 2018	782.40M	221.50M	39.49%
Dec 31, 2017	560.90M	72.10M	14.75%
Dec 31, 2016	488.80M	-531.00K	-0.11%
Dec 31, 2015	489.33M	84.87M	20.98%
Dec 31, 2014	404.47M	91.72M	29.33%
Dec 31, 2013	312.75M	30.86M	10.95%
Dec 31, 2012	281.89M	8.50M	3.11%
Dec 31, 2011	273.38M	-12.79M	-4.47%
Dec 31, 2010	286.17M	51.39M	21.89%
Dec 31, 2009	234.79M	56.23M	31.49%
Dec 31, 2008	178.55M	-4.36M	-2.38%
Dec 31, 2007	182.92M	30.18M	19.76%
Dec 31, 2006	152.73M	22.04M	16.87%
Dec 31, 2005	130.69M	-	-